In animal models of MS, fecal microbiota transplantation (FMT) is associated with a decrease in axonal damage markers (e.g., myelin binding protein and neurofilament light polypeptide (NFL)), intact myelin sheaths in the thoracic spinal cord, and a reduction in the number of activated microglia [61]. Here, NEFL is linked to myeloid sarcoma.